Next-generation Surgical Glue Market is projected to increase at a CAGR of 7.65% from 2022 to 2031, to exceed USD 4.3 billion

Surgical glue is a polymer that is used to repair major as well as minor wounds, including, incisions made during laparoscopic surgery, lacerations, and wounds on the groin or in the face. The surgical glue is also known as "liquid stitches", "tissue adhesive" or "2-octyl cyanoacrylate (DERMABOND)". In addition, this glue has several benefits as compared to conventional staplers and surgical sutures which include less scarring, lower rates of infection, no stitches to remove, and lesser time in the operating room among others.

Download Sample PDF Of This Report:
https://www.globalinsightservices.com/request-sample/GIS10535/?utm_id=1018

Market Drivers and Trends
Some of the factors contributing to the growth of the next-generation surgical glue market are the rising number of traumatic injuries, the growing number of surgical procedures and burn cases, in couple with the increasing incidences of road accidents worldwide. In addition, the growing health awareness in addition to the high prevalence of several diseases which includes respiratory diseases, heart diseases, cancer, and skin diseases have augmented the opportunities for surgeries globally. For instance, as per the World Health Organization (WHO) report 2020, nearly 1.35 million people die every year due to road traffic crashes. In addition, nearly 20-50 million people experience non-fatal injuries, with many experiencing a disability as a result of their injury. Over 90% of the global fatalities on the roads happen in low and middle-income nations, although these nations have around three-fifths of the world's vehicles. Therefore, the growing occurrence of diseases accompanied by road injury cases is anticipated to drive the next-generation surgical glue market growth.

Further, surgical glue is rapidly achieving clinical approval on the back of the growth in demand for cutting-edge hemostasis products for advancing surgical outcomes in diverse medical specialties. Major companies in the next-generation surgical glue market are orientated on enhancing the user-friendliness, efficacy, as well as safety of adhesives & sealants used for closing incisions in traumatic injuries. This, in turn, has led to the initiation of ergonomic designs in the next-gen surgical glue market.

Further, the other factor boosting the growth of the Next-generation Surgical Glue Market is a rise in the prevalence of cardiovascular and orthopedic disorders. Besides, the growth of the Next-generation Surgical Glue Market is also attributed to the growing demand for high-performance and efficient surgical products globally. Increasing awareness regarding the benefits of the Next-generation Surgical Glue Market is expected to positively impact the revenue growth of the market over the forecast period. In addition, developments in Next-generation Surgical Glue positively contribute to the growth of the Next-generation Surgical Glue Market. Further, the rising demand for Next-generation Surgical Glue from emerging economies to treat patients suffering from various diseases effectively is expected to cater to the growth of the Next-generation Surgical Glue industry. Furthermore, technological advancements in Next-generation Surgical Glue are anticipated to offer lucrative opportunities for the market players.

Request Customization:
https://www.globalinsightservices.com/request-customization/GIS10535/?utm_id=1018

Next-generation Surgical Glue Market Segmentation
The report analyses the Next-generation Surgical Glue Market based on type, application, end-user, and region.

Major Players of the Next-generation Surgical Glue Market
The Next-generation Surgical Glue Market report includes players such as Grünenthal Group, Braun Melsungen AG, Becton, Dickinson, and Company, Baxter International Inc., Advanced Medical Solutions Group plc, Cardinal Health Inc., CryoLife Inc., Johnson & Johnson, Medtronic plc, and Integra LifeSciences Corporation.

COVID-19 Analysis
The COVID-19 pandemic is expected to have a positive impact on the global surgical glue market. As per the National Library of Medicine, there were nearly 1,307 cases of bariatric surgeries in 2020 in India. There were over 85 patients who were COVID positive and underwent bariatric surgeries. Therefore, a rise in the number of surgeries has led to an increase in the usage of surgical glue. Thus, new technological innovations by major players and a rise in the number of product approvals are anticipated to lead to the growth of the next-generation surgical glue market.

Recent Developments
In December 2021, Becton, Dickinson, and Company acquired Tissuemed, Ltd., an England-based, privately-held company, a leader in developing self-adhesive surgical sealant films. This acquisition helped the company to expand its product offerings for surgeons outside the U.S.
In November 2020, TISSIUM, a MedTech company, received approval from the FDA for its Investigational Device Exemption (IDE) application for its vascular sealant in pre-filled syringe format.
In February 2020, Baxter International Inc., a leading medical products company, acquired Seprafilm Adhesion Barrier and related assets from Sanofi for approximately $350 million. This acquisition will help the company to expand its product offerings for surgeon and hospital customers globally.

Procure Complete Report (PDF with Insights, Charts, Tables, and Figures)
https://www.globalinsightservices.com/checkout/single_user/GIS10535/?utm_id=1018

Contact Us:
Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700
Website: https://www.globalinsightservices.com/

About Global Insight Services:

Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.

This release was published on openPR.